FDA warns Novartis over contaminated vaccines

The FDA has warned Novartis Vaccines and Diagnostics of the "significant deviations" found at its manufacturing plant in Marburg, Germany, accusing the pharma giant of producing contaminated vaccines and failing to come up with a comprehensive response to the problem. In a letter to Novartis Vaccines CEO Joerg Reinhardt, the FDA said an inspection last September "documented a number of significant deviations from current good manufacturing practices in the manufacture of your Rabies Vaccine and Diphtheria and Tetanus Toxoids Adsorbed concentrate." The agency went on to chide the company for failing to come up with a comprehensive plan to correct the issues and warned of new regulatory actions that could follow.

- check out the FDA letter

Suggested Articles

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

AstraZeneca scored a $1 billion contribution from the United States for development, production and delivery of its potential COVID-19 vaccine.

AZ is among the companies leading the COVID-19 vaccine race, and after agreeing first to supply the U.K., it's now in talks for delivery worldwide.